Skip to main content
. 2021 May 13;12:573065. doi: 10.3389/fphar.2021.573065

FIGURE 6.

FIGURE 6

hMSC Effect on PPARγ and TNFα expression. BMDM from CF patients and CF mice were evaluated for PPARγ (A). Sputum was obtained from CF patients (n = 3) and compared to healthy control (n = 3), demonstrating deficient PPARγ (p ≤ 0.05). BMDM from Cftr deficient mice also had deficient expression of PPARγ (p ≤ 0.05). (B) BMDM were stimulated with LPS and processed for PPARγ and TNFα gene expression demonstrating a decreased of PPARγ (p ≤ 0.05) and increased TNFα (p ≤ 0.05) relative to the unstiluated control of PPARγ and TNFα (2.1 ± 0.07 dCT and 1.7 ± 1.0 dCt respectively, n = 3) at baseline. The same culture conditions were done in the presence of hMSC condition medium. hMSC supernatants increased PPARγ and decreased TNFα (p ≤ 0.05) above the baseline controls.